What is Methylene Blue? History, Uses, and Modern Applications

For a deeper look at the chemistry and manufacturing process, see our guide on how methylene blue is actually made.

Methylene blue is the first fully synthetic drug ever used in medicine. Few compounds have a record that spans 150 years of continuous medical relevance, and fewer still have crossed from industrial chemistry into present-day longevity research.

Origins: From Dye Factory to Medical Breakthrough (1876–1891)

German chemist Heinrich Caro synthesized methylene blue in 1876 at BASF in Ludwigshafen while developing new dyes for the textile industry. The compound was a thiazine dye that produced an intense, stable blue color on cotton fibers. For the first decade of its existence, methylene blue was purely an industrial chemical with no medical purpose.

That changed in 1886 when Paul Ehrlich, later a Nobel laureate, discovered that methylene blue selectively stained live nerve cells and, crucially, had a similar affinity for Plasmodium parasites in human blood. Ehrlich recognized that a compound capable of binding selectively to specific biological targets might serve as a therapeutic agent rather than just a laboratory stain. In 1891, Ehrlich and Paul Guttmann administered methylene blue to two malaria patients and documented clinical improvement, making methylene blue the first synthetic compound used to treat an infectious disease in humans.

This work was foundational. Ehrlich’s principle of selective toxicity — that chemicals could target disease organisms while sparing host cells — became the intellectual basis for modern pharmacology. Methylene blue was the prototype compound that inspired the development of chloroquine and other synthetic antimalarials, antihistamines, and eventually antipsychotic medications. The phenothiazine class of drugs, which includes chlorpromazine (the first antipsychotic), is structurally derived from methylene blue’s chemical scaffold.

A Century of Medical Applications

After its debut as an antimalarial, methylene blue accumulated an unusually broad list of medical uses over the following century.

Methemoglobinemia treatment. Methylene blue acts as an electron carrier that reduces methemoglobin back to functional hemoglobin. In methemoglobinemia — a condition in which hemoglobin cannot carry oxygen properly — intravenous methylene blue is the standard first-line treatment. This remains its most widely recognized clinical application, and injectable methylene blue (marketed as ProvayBlue) is on the World Health Organization’s List of Essential Medicines.

Surgical dye and diagnostic agent. Surgeons use methylene blue as a tissue-marking dye during procedures involving lymph nodes, fistula tracts, and urological structures. Its strong affinity for biological tissues makes it useful for identifying anatomical structures that are otherwise difficult to distinguish visually.

These are clinical and surgical applications, not supplement use; for the low-dose context, see NooBlue for mental clarity.

Cyanide and carbon monoxide poisoning antidote. In 1933, researcher Matilda Brooks showed that methylene blue could treat cyanide poisoning by restoring mitochondrial electron transport. This application expanded to carbon monoxide poisoning, where methylene blue helps restore oxygen-carrying capacity to compromised hemoglobin.

Antimicrobial and antiseptic. Methylene blue has broad antimicrobial properties and was used as a urinary antiseptic before the development of modern antibiotics. It continues to see use in some regions for treating urinary tract infections and as a topical antiseptic for wound care.

The Mitochondrial Process: Why Researchers Came Back to Methylene Blue

The renewed scientific interest in methylene blue since the early 2000s centers on a property that was always present in the compound but not fully understood until modern mitochondrial biology provided the framework: methylene blue functions as an alternative electron carrier in the mitochondrial electron transport chain.

At low strengths, methylene blue accepts electrons from NADH and FADH2 and donates them directly to cytochrome c, creating a shortcut that bypasses Complexes I, II, and III. This bypass increases the activity of Complex IV (cytochrome c oxidase) and enhances the rate at which mitochondria convert oxygen into ATP, the primary energy currency of every cell.

A landmark 2008 study by Atamna and colleagues, published in The FASEB Journal, showed that nanomolar strengths of methylene blue delayed cellular senescence in human fibroblasts by more than 20 population doublings. The process involved a 30% increase in mitochondrial Complex IV activity, a 37–70% increase in cellular oxygen consumption, and enhanced heme synthesis (Atamna et al., 2008). Telomere erosion rates were greatly lower in methylene blue-treated cells, suggesting that the compound protected cells from age-related decline at a fundamental genetic level.

A follow-up study confirmed that methylene blue activated AMPK phosphorylation, which triggered expression of PGC1-alpha and SURF1 — two key regulators of mitochondrial biogenesis. Treated cells showed more than 100% increase in Complex IV activity and a 28% decline in cellular oxidants (Atamna et al., 2015).

Modern Applications: Nootropics, Neuroprotection, and Longevity

The convergence of mitochondrial research, aging biology, and nootropic science has positioned methylene blue as a compound of serious interest in several overlapping fields.

The amounts involved in this context are small, typically 5–20 mg a day; our daily dosage guidelines set out the ranges by goal.

Cognitive enhancement and memory. Low-dose methylene blue improves memory consolidation by increasing cytochrome oxidase activity in brain regions with the highest metabolic demands during learning. Published human studies have documented improved fear extinction memory, enhanced contextual memory, and increased resting-state functional connectivity between brain regions involved in attention and perception.

Neuroprotection. In preclinical models, methylene blue has shown protective effects against neurodegeneration in stroke, Alzheimer’s disease, Parkinson’s disease, and traumatic brain injury models. The process is consistent across models: by maintaining cell energy output under oxidative stress, methylene blue preserves the energy supply that neurons need to survive insults that would otherwise trigger cell death.

Anti-aging and cellular longevity. The Atamna laboratory’s work on senescence delay has been extended by other research groups examining methylene blue’s effects on skin aging, skeletal muscle aging, and broader markers of biological age. The compound’s ability to simultaneously enhance energy production and reduce oxidative stress makes it a candidate for interventions targeting the mitochondrial theory of aging.

Supplemental use. Pharma-grade methylene blue is available as an oral supplement in both liquid and capsule formats. NooBlue’s Ultimate Methylene Blue Capsules (5 mg) and 1% liquid solution are USP-grade products formulated for low-dose daily use. The typical supplemental dose range is 5–20 mg per day — far below the clinical doses used for methemoglobinemia treatment. Browse the full product range at the NooBlue shop.

How Is Methylene Blue Made? Synthesis and Pharmaceutical Grade

Modern methylene blue is produced through a multi‑step organic synthesis starting from N,N‑dimethylaniline and sodium thiosulfate, with intermediate oxidation steps using sodium dichromate or aluminium sulfate to form the phenothiazine core that gives the molecule its signature deep‑blue colour. The final compound — chemically 3,7‑bis(dimethylamino)phenothiazin‑5‑ium chloride — is purified through repeated crystallisation, washing, and drying.

The grade you end up with depends entirely on what happens after synthesis:

• USP grade (pharmaceutical): >99% purity, residual heavy metals tested below pharmacopoeial limits, organic solvent residues controlled, full COA per batch. This is the only grade appropriate for human ingestion.
• Reagent / lab grade: ~96–98% purity, used for histological staining and laboratory assays. Not tested or labelled for oral use.
• Industrial / technical grade: ~80–90% purity, often retains residues from textile‑dye and aquaculture supply chains. Unsafe to ingest.

This grade distinction is why the same compound name covers both a hospital‑administered drug for methemoglobinaemia and a $4 aquarium bottle — and why every reputable supplement vendor publishes a third‑party Certificate of Analysis. For a side‑by‑side breakdown, see lab‑grade vs pharmaceutical‑grade methylene blue.

What Methylene Blue Is Made Of: Formula, Names, and Appearance

The molecule behind every product on this page has the formula C₁₆H₁₈ClN₃S and a molar mass of about 319.85 g/mol. It is a chloride salt: the colored part is a positively charged phenothiazinium cation, a three-ring core in which two benzene rings are joined through a nitrogen atom and a sulfur atom, with a dimethylamino group on each outer ring. Despite the name, the structure contains no methylene (CH₂) bridge; the four methyl groups sit on its two nitrogen atoms, and the name dates from 1876, not modern nomenclature.

It also goes by several aliases: methylthioninium chloride (the nonproprietary name used for the injectable drug), Basic Blue 9 and C.I. 52015 (dye-industry designations), and tetramethylthionine chloride. As a solid it is a dark green crystalline powder with a bronze sheen; the familiar deep blue appears only once it dissolves in water.

2026 Research Snapshot: What Peer-Reviewed Evidence Currently Supports

The modern interest in low‑dose methylene blue is built on a specific mitochondrial mechanism. Research published in Progress in Neurobiology describes methylene blue as an electron carrier with a hormetic dose‑response curve — benefits cluster at low doses (typically 0.5–4 mg/kg in animal models) and reverse at higher doses (Rojas et al., Progress in Neurobiology (2012) — PMID 22067440). Subsequent work in Biochemical Pharmacology framed mitochondrial respiration itself as a therapeutic target for cognitive enhancement, with low‑dose USP methylene blue as a primary pharmacological example (Gonzalez-Lima et al., Biochemical Pharmacology (2014) — PMID 24316434). A 2020 study in rats with chronic cerebral hypoperfusion found that 4 mg/kg methylene blue preserved cytochrome oxidase activity across visual, prefrontal, perirhinal, hippocampal, and amygdalar regions, and prevented memory impairment (Auchter et al., Frontiers in Cellular Neuroscience (2020) — PMID 32508596).

What this evidence does not say: methylene blue is a treatment, cure, or substitute for medical care. It says low‑dose USP‑grade methylene blue improves a specific bioenergetic readout in controlled models. That nuance is why we recommend treating it as a research‑backed supplement and curating products from vendors that meet the same purity standard the studies used.

How Methylene Blue Works: Mechanism of Action

Almost every modern claim made about methylene blue traces back to one mechanism, so it is worth setting out precisely. In the mitochondrial electron transport chain, electrons normally pass from NADH through Complex I, then to Complex III via coenzyme Q, then to cytochrome c, and finally to Complex IV, where oxygen is reduced to water and the resulting proton gradient drives ATP synthesis. Damage or slowdown anywhere along that chain reduces the whole output.

Methylene blue does something unusual: it can accept electrons directly from NADH and donate them straight to cytochrome c, bypassing Complexes I and III entirely. Because it is a small, lipophilic, redox-active molecule, it cycles continuously between its oxidised form (MB⁺) and its reduced form (leucomethylene blue, MBH₂) rather than being consumed. A single molecule can therefore shuttle electrons many times over. A review in Molecular Neurobiology (Tucker et al., 2018, Molecular Neurobiology — PMID 28840449) summarises this rerouting and the associated increase in Complex IV activity.

Why the dose direction matters more than the dose size. This electron shuttling only works while methylene blue is being efficiently recycled. Once the concentration exceeds what the surrounding redox environment can turn over, the excess stops acting as a carrier and starts generating reactive oxygen species — the opposite of the intended effect. That reversal is what makes the dose–response curve hormetic rather than linear, and it is why the research literature clusters around low doses instead of treating “more” as better. A review in Progress in Neurobiology (Rojas et al., 2012, Progress in Neurobiology — PMID 22067440) describes this curve directly, with benefits clustering at roughly 0.5–4 mg/kg in animal models and reversing above that band.

Getting there from an oral dose. A mechanism only matters if the compound actually reaches circulation. A Phase I randomised controlled trial in human volunteers measured the absolute bioavailability of an aqueous oral formulation at roughly 72% (Walter-Sack et al., 2009, European Journal of Clinical Pharmacology — PMID 18810398), which is high for an orally dosed small molecule and explains why modest oral microdoses produce meaningful plasma concentrations. Our methylene blue dosage chart translates that into practical ranges by goal and body weight.

What the Research Currently Shows

The evidence base splits cleanly into three tiers, and conflating them is where most online writing about methylene blue goes wrong.

Human pharmacology — well established. Absorption, distribution and the redox behaviour of the molecule itself are characterised in human subjects, as in the bioavailability trial above. This tier tells you what the compound does in a body; it does not tell you what it does for cognition.

Mechanistic and animal work — the bulk of the interest. A 2008 study in The FASEB Journal (Atamna et al., 2008 — PMID 17928358) found nanomolar methylene blue delayed senescence in human fibroblasts while raising Complex IV activity, and follow-up work in Redox Biology (Atamna et al., 2015 — PMID 26386875) linked the effect to AMPK activation and mitochondrial biogenesis regulators. In animals, a study in Frontiers in Cellular Neuroscience (Auchter et al., 2020 — PMID 32508596) reported that 4 mg/kg methylene blue preserved cytochrome oxidase activity and prevented memory impairment in rats with chronic cerebral hypoperfusion. A review in Biochemical Pharmacology (Gonzalez-Lima et al., 2014 — PMID 24316434) framed mitochondrial respiration itself as a target for cognitive enhancement, with low-dose methylene blue as its worked example.

Preclinical disease models — early and often misreported. Work in Advanced Materials (Liu et al., 2024 — PMID 38395039) and a review in Reviews in the Neurosciences (Isaev et al., 2024 — PMID 38530227) cover tau aggregation and neuroprotection mechanisms in animal and cell models. These are hypothesis-generating, not conclusions about people.

Read that hierarchy honestly: methylene blue has a well-characterised mechanism, a strong pharmacokinetic profile in humans, and a body of animal and cell evidence. It is not a treatment for any condition, and the animal results have not been reproduced as human outcomes. We sell it as a research-backed supplement and we think the distinction is worth stating plainly.

Common Uses for Methylene Blue Today

Modern use falls into three groups. In laboratories it remains a standard histological and microbiological stain, which is where most people first encounter the name. In clinical settings it is administered by clinicians for specific indications at doses far above any supplemental amount. And as a consumer supplement, low-dose USP-grade methylene blue is taken orally for mitochondrial and cognitive support — the use this site covers. The three are not interchangeable, and neither the laboratory nor the clinical form should be taken orally: only USP or pharmaceutical grade is purified to the standard required for ingestion. Our guide to lab-grade versus pharmaceutical-grade methylene blue explains what separates them, and how to test whether methylene blue is real covers verifying what you already own.

Key Takeaways

Three points carry this article. Methylene blue is a fully synthetic phenothiazine dye, first made by Heinrich Caro in 1876 from N,N-dimethylaniline and sulfur reagents, and it became the first synthetic compound used as a medicine when Ehrlich and Guttmann gave it to malaria patients in 1891. It is still studied for one reason: at low concentrations it accepts electrons from NADH and passes them to cytochrome c, bypassing Complexes I and III, and that effect flips to pro-oxidant once the dose climbs, which is why the research clusters at low doses. For supplemental use that means a conservative routine: most people start with one 5 mg capsule in the morning, keep any dose before about 2 PM, never combine it with SSRIs, SNRIs or other serotonergic drugs, and do not use it at all with G6PD deficiency, pregnancy or breastfeeding.

The third point is grade. The same molecule is sold at industrial, laboratory and pharmaceutical purities, and only USP or pharmaceutical grade at 99%+ purity, with a per-batch Certificate of Analysis covering heavy metals and solvent residues, is fit to swallow. The aquarium bottle and the hospital vial contain the same compound; the certificate is what separates them.

For a closer look at which formulas meet that bar, see our best methylene blue gummies roundup, or check our guide to finding methylene blue near you if you would rather buy in person at a health store or pharmacy.

Frequently Asked Questions

Is the methylene blue in supplements the same compound used in hospitals?

Yes. The active chemical is identical: 3,7-bis(dimethylamino)-phenothiazin-5-ium chloride. The difference between a hospital formula and a dietary supplement is the delivery route (injectable vs. oral), and the dosage (clinical intravenous doses are far larger than the 5–20 mg oral microdoses used in supplements). Both clinical and supplemental products should be USP pharma-grade — the purity standard is the same regardless of end use.

For more details, see our methylene blue absorption rate.

Why does methylene blue work at low doses but not high doses?

Methylene blue follows a hormetic dose-response curve. At low strengths (nanomolar to low micromolar range), it cycles between its oxidized form (MB+) and its reduced form (MBH2) in mitochondria, acting as an electron carrier that enhances energy production and reduces oxidative stress. At high strengths, the excess methylene blue overwhelms the recycling capacity, and the compound begins to act as a pro-oxidant that generates reactive oxygen species instead of neutralizing them. This is why the published literature consistently emphasises low-dose protocols.

Is methylene blue safe for daily use?

At the low doses typically used in supplements (5–20 mg daily), methylene blue has a long safety record in published research. The most common effects are harmless blue-green discoloration of urine and, with liquid dosing, temporary blue staining of the mouth and tongue. Methylene blue is a monoamine oxidase inhibitor (MAO-I) and must not be combined with SSRIs, SNRIs, MAOIs, St. John’s Wort, 5-HTP, or tryptophan due to the risk of serotonin syndrome. People with G6PD deficiency should avoid methylene blue entirely. Consult a healthcare provider before starting if you take any prescription medications. For more on this, see our guide on whether you need a prescription for methylene blue.

What is the connection between methylene blue and chloroquine?

Chloroquine was directly developed from methylene blue. After Ehrlich showed that methylene blue could treat malaria by selectively targeting Plasmodium parasites, pharmaceutical chemists spent decades modifying its chemical structure to create more potent and better-tolerated antimalarials. Chloroquine, synthesized in the 1930s and widely deployed during World War II, is a structural descendant of methylene blue. The same design principle — a heterocyclic aromatic compound that accumulates in the parasite’s food vacuole — links both drugs. Methylene blue itself saw military use as an antimalarial when chloroquine supplies ran low during the war, though soldiers reportedly objected to the blue discoloration of their urine.

Is methylene blue a natural dye or a synthetic one?

Synthetic, entirely. Methylene blue does not occur in any plant, animal or mineral. Heinrich Caro made it in a BASF laboratory in 1876 from N,N-dimethylaniline and sulfur-containing reagents, which puts it among the earliest fully synthetic dyes, unlike plant-derived colors such as indigo. For buyers, that means “natural” is not a quality marker. An aquarium bottle and a hospital vial contain the same man-made molecule; what separates them is purification, so the useful question for a vendor is whether the material is USP grade with a per-batch Certificate of Analysis.

How do you take methylene blue orally?

Start low and dose early. Most people begin with one 5 mg capsule in the morning and hold there for two weeks before adjusting. With the 1% solution one drop is roughly 0.5 mg, so 10 drops equals a capsule; dilute them in water to limit tongue and tooth staining. Gummies fix the dose at 10 mg. Keep every dose before about 2 PM, never combine it with SSRIs, SNRIs or other serotonergic drugs, and skip it entirely with G6PD deficiency, pregnancy or breastfeeding. Our guide to taking methylene blue drops covers dilution and timing.

What are the disadvantages of methylene blue?

The main practical disadvantages are temporary blue-green discoloration of urine, occasional staining of teeth or tongue when taken as a liquid, and serious drug-interaction risk with serotonergic medications because methylene blue is a reversible monoamine oxidase inhibitor. People with G6PD deficiency are advised to avoid methylene blue because it can trigger hemolytic anemia. At doses above the hormetic range (over 10 mg/kg), methylene blue can become pro-oxidant rather than antioxidant, which is why supplement doses stay between 5 and 20 mg daily.

Can I take methylene blue every day?

Daily low-dose methylene blue (5–20 mg) has been used in published research without serious adverse effects in healthy adults, and many longevity-focused users follow daily protocols. Best practice is to start with the lowest available dose, monitor tolerance over the first two weeks, and cycle off periodically (for example, five days on, two days off) to assess your individual response. Anyone on prescription medication, especially antidepressants, should consult a qualified healthcare provider before starting daily methylene blue.

How is methylene blue made today?

Modern pharmaceutical methylene blue is synthesised from dimethylaniline through a multi-step oxidation process originally developed by Heinrich Caro in 1876. Today’s USP-grade material is produced under Good Manufacturing Practice (GMP) conditions, then purified through recrystallisation to remove residual heavy metals, formaldehyde, and other process impurities. The finished USP-grade powder must meet purity specifications of 99% or higher and pass independent testing for microbial contamination. Industrial-grade and laboratory-grade methylene blue use the same synthesis route but skip the final pharmaceutical purification — which is why grade distinction matters for any methylene blue intended for oral use.

How does methylene blue work in the body?

At low doses it acts as an electron cycler in mitochondria: it accepts electrons from NADH and donates them directly to cytochrome c, bypassing Complexes I and III and raising Complex IV activity. Because it is regenerated rather than consumed, one molecule can carry electrons repeatedly. Above a certain concentration the behaviour reverses and it acts as a pro-oxidant instead, which is the reason low-dose protocols dominate the literature.

Is methylene blue the same as the industrial dye?

Chemically it is the same molecule, but industrial and laboratory grades are not purified to the standard required for ingestion and can carry heavy-metal and solvent residues from manufacture. Only USP or pharmaceutical-grade material, with a Certificate of Analysis confirming 99%+ purity, should ever be considered for oral use.

How long has methylene blue been studied?

Since 1876, when Heinrich Caro first synthesised it as a textile dye. It became the first fully synthetic compound used as a medicine and has one of the longest continuous research records of any small molecule still under active study today.

Why don’t doctors prescribe methylene blue for everyday use?

Because the everyday use people are asking about is not what it is licensed for. Methylene blue has a narrow set of established clinical indications, and those are handled in hospital under supervision. The low-dose oral use discussed on this page is a supplement context, supported mostly by mechanistic and animal research rather than by large human trials at supplement doses. A clinician has no established protocol to prescribe against, and there is a real interaction hazard with serotonergic medication, so the sensible clinical answer is caution rather than endorsement. We look at the reasoning in full in why doctors don’t prescribe methylene blue.

Is methylene blue toxic to your body?

Dose and route decide that. At the low oral amounts used in a supplement context it is generally well tolerated in healthy adults; at high doses it reverses from antioxidant to pro-oxidant, and at clinical intravenous doses it has a defined toxicity threshold. Two groups face a genuine risk at any dose: anyone taking serotonergic medication, because of MAO inhibition and serotonin syndrome, and anyone with G6PD deficiency, because of haemolysis. Blue-green urine is expected rather than a toxicity signal. See our side effects guide and who should not take methylene blue.

Why do I feel weird after taking methylene blue?

The usual explanations are mundane. A dose at the higher end of your tolerance, taking it on an empty stomach, taking it late enough to disturb sleep, or simply the first few days of adjustment all produce the vague off feeling people describe — mild nausea, a slightly wired edge, a headache. The useful test is whether it tracks your dose: if it appeared when you increased and eases when you step back down, that is the answer. If it does not, or if it is severe, stop and get medical advice, particularly if you take any serotonergic medication. We go through the possibilities in why methylene blue can make you feel weird.

Is methylene blue found in food, or is there a natural substitute?

No, and not really. Methylene blue is a synthetic compound — it was manufactured as a textile dye in 1876 and does not occur in food. As for substitutes, nothing in the natural-products world works the way it does, because its defining property is that it can act as an artificial electron carrier inside the electron transport chain. Compounds often suggested as alternatives, such as CoQ10, PQQ or NAD precursors, support mitochondrial function through entirely different routes rather than replicating that bypass. If you are comparing options, our methylene blue vs NAD comparison and mitochondrial support supplements guide set out the differences.

What forms is methylene blue sold in for oral use?

Three, and they differ in granularity rather than in the compound itself. A 1% solution delivers about 0.5 mg per drop, which gives the finest control and the lowest cost per milligram, at the price of measuring and the familiar blue mouth. Capsules fix the dose at 5 mg a unit and bypass the mouth entirely. Gummies fix it at 10 mg; the version we make pairs the methylene blue with vitamin C, which reduces it to colourless leucomethylene blue inside the gummy, so the blue-mouth problem does not arise and the purple colour comes from blueberry extract rather than the active. Whichever you pick, the thing to verify is grade: USP or pharmaceutical grade with a published Certificate of Analysis. Our gummies guide, capsules vs liquid comparison and daily dosing guide cover the choice in more detail.

Related reading: Methylene Blue Dosage Chart · Best Methylene Blue Supplements 2026 · How Long Does Methylene Blue Take to Work? · Where to Buy Methylene Blue · Shop NooBlue